Plant · Scientific monograph
Sambucus nigra
Elderberry / Black elder
For educational and scientific research only. Not medical advice. Independently verify claims against the cited primary sources. Consult a qualified healthcare professional before using any plant or fungal preparation.
Research areas: Viral Mechanisms Research, Immunological Research, Inflammatory Pathways
Research overview
Historical use
Sambucus nigra has been used medicinally across Europe and the Americas for millennia. Flowers (Flos Sambuci) were employed to reduce fever, soothe respiratory catarrh, and treat skin disorders; ripe berries (Fructus Sambuci) were made into syrups, wines, and decoctions for influenza, colds, and constipation. The plant features in the materia medica of Hippocrates, Dioscorides, and Galen, and was known as the 'medicine chest of the country people' in 17th-century England. Indigenous North American peoples used elderberry preparations for infections, pain relief, and as a purgative.
Modern research context
Elderberry extracts are among the most clinically studied herbal antivirals. A 2026 ethnopharmacological review confirms activity against influenza, SARS-CoV-2, RSV, and other RNA viruses through inhibition of viral surface proteins hemagglutinin and neuraminidase [1, 8]. In vitro studies demonstrate synergistic antiviral effects when combined with iota-carrageenan [4] and quinine [5]. A 2026 randomised, double-blind, placebo-controlled clinical trial found significant reductions in paediatric respiratory tract infection frequency and severity with an elderberry-containing supplement [3]. Reviews document additional cardioprotective [2], antidiabetic, antioxidant, and neuroprotective activities [1, 6]. A 2025 transcriptomic study in overweight adults showed one week of elderberry juice significantly altered gene expression toward enhanced metabolic flexibility and insulin signalling [7].
Adverse effects
Processed elderberry preparations are generally well-tolerated at standard doses. Rare gastrointestinal effects (nausea, vomiting) with excessive intake. Raw unripe berries, seeds, bark, and leaves contain the cyanogenic glycoside sambunigrin, causing nausea and emesis if consumed raw; heating or processing eliminates this compound [1, 6]. Theoretical immunostimulatory activity may aggravate autoimmune conditions.
Contraindications
Raw, unprocessed plant material contraindicated in all populations. Caution warranted in patients on immunosuppressants (calcineurin inhibitors, corticosteroids) due to opposing immunostimulatory activity [1]. Avoid in known hypersensitivity to Sambucus species or the Adoxaceae family.
Clinical and phytochemical data
Used part
Ripe berries (Fructus Sambuci), flowers (Flos Sambuci)
Primary active compounds
Cyanidin-3-glucoside (anthocyanin)
Cyanidin-3-sambubioside (anthocyanin)
Quercetin
Rutin
Kaempferol
Chlorogenic acid
Sambunigrin (cyanogenic glycoside, raw plant only)
Mechanism of action
Antiviral activity mediated through direct binding to viral hemagglutinin and neuraminidase surface proteins, blocking host-cell sialic acid receptor recognition and viral entry [4, 5, 8]. Anthocyanins activate TLR4/NF-κB and MAPK signalling, stimulating innate immune cytokine production (TNF-α, IL-6, IL-1β) [1]. Antioxidant activity via Nrf2/HO-1 pathway induction and direct free-radical scavenging by phenolic hydroxyl groups [6]. Cardioprotective effects involve eNOS upregulation, inhibition of LDL oxidation, and attenuation of NF-κB-driven vascular inflammation [2].
Pharmacokinetics
Absorption
No human pharmacokinetic data are available for this species. The following is derived from preclinical animal studies and in vitro data only, and may not reflect human pharmacology. — Elderberry anthocyanins are absorbed in the gastrointestinal tract with low absolute oral bioavailability. Cyanidin-3-glucoside and cyanidin-3-sambubioside demonstrate rapid absorption in animal models; peak plasma concentrations are reached within 0.5–1 hour post-administration. Bioavailability is limited (<5%) due to extensive presystemic metabolism by intestinal epithelium and colonic microbiota, converting anthocyanins to simpler phenolic acids [1, 6].
Distribution
No human pharmacokinetic data are available for this species. The following is derived from preclinical animal studies and in vitro data only, and may not reflect human pharmacology. — In rodent models, anthocyanins and their phenolic acid metabolites distribute widely to vascular tissues, liver, kidneys, and bladder epithelium. Plasma protein binding of elderberry flavonoids (quercetin, rutin) exceeds 80–90%, predominantly to albumin [6].
Metabolism
No human pharmacokinetic data are available for this species. The following is derived from preclinical animal studies and in vitro data only, and may not reflect human pharmacology. — Cyanidin glycosides undergo rapid hydrolysis by intestinal β-glucosidases and gut microbiota, releasing cyanidin aglycone, which is further ring-opened to protocatechuic acid and phloroglucinaldehyde. Phase II hepatic conjugation (glucuronidation, sulfation, O-methylation) generates circulating metabolites including quercetin-3-glucuronide and isorhamnetin [1, 6].
Excretion
No human pharmacokinetic data are available for this species. The following is derived from preclinical animal studies and in vitro data only, and may not reflect human pharmacology. — Elimination is primarily renal for phase II-conjugated phenolic metabolites; <1% of intact anthocyanins is recovered in urine. Biliary excretion accounts for elimination of high-molecular-weight glucuronide and sulfate conjugates [6].
Safety and interactions
Drug interactions
Lack of clinical studies prevents interaction grading. Unknown safety profile with concomitant drug use.
Toxicity
Acute oral toxicity of processed elderberry preparations is low. Standardised elderberry extract has been administered across multiple clinical trials without hepatotoxic or haematological adverse signals [3]. Raw plant material containing sambunigrin is toxic; cooking or commercial processing eliminates this risk [1, 6].
Special precautions
Pregnancy
Insufficient clinical safety data. Processed berry extracts at normal dietary doses are likely low-risk, but medicinal-dose supplements are not recommended during pregnancy due to absence of controlled trials.
Lactation
Excretion of elderberry constituents in human breast milk is unstudied. Medicinal-dose supplements not recommended.
Hepatic impairment
No specific clinical data. Standard hepatic precautions apply; avoid concentrated extracts in severe hepatic impairment.
Renal impairment
No specific data. Standard precautions apply at normal supplement doses.
Sources and references
- [1] - Khalil AM, Kamal RM, El-Shiekh RA, Elbanna AH, Hamdy SA., "Elderberry (Sambucus nigra L.): an ethnopharmacological, phytochemical and biological review for a prospective nutraceutical plant.", Inflammopharmacology, 2026, PMID: 41665742
- [2] - Olas B., "Comparative Review of Cardioprotective Potential of Various Parts of Sambucus nigra L. and Their Products.", International Journal of Molecular Sciences, 2026, PMID: 41516333
- [3] - Calapai F, Ammendolia I, Mannucci C et al., "Evaluation of the Effects of an Immune-Boosting Food Supplement on Paediatric Respiratory Tract Infections: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial.", Children (Basel), 2026, PMID: 41897140
- [4] - Setz C, Setz M, Rauch P et al., "Synergistic Virus Neutralizing Activities of European Black Elderberry Fruit Extract and Iota-Carrageenan Against SARS-CoV-2, Influenza A Virus and RSV.", Nutrients, 2026, PMID: 42075018
- [5] - Setz C, Rauch P, Setz M et al., "Synergistic Antiviral Activity of European Black Elderberry Fruit Extract and Quinine Against SARS-CoV-2 and Influenza A Viruses.", Nutrients, 2025, PMID: 40218964
- [6] - Ren Y, Meyer G, Anderson AT et al., "Development of Potential Therapeutic Agents from Black Elderberries (the Fruits of Sambucus nigra L.).", Molecules, 2024, PMID: 38998923
- [7] - Teets C, Etter AJ, Solverson PM., "One-Week Elderberry Juice Intervention Promotes Metabolic Flexibility in the Transcriptome of Overweight Adults During a Meal Challenge.", Nutrients, 2025, PMID: 41097219
- [8] - Cañedo-Figueroa DM et al., "Natural Compounds with Antiviral Activity Against Clinically Relevant RNA Viruses: Advances of the Last Decade.", Biomolecules, 2025, PMID: 41154696